Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06003725 · ClinicalTrials.gov registry record · NA
Cultural Adaptation of Drug Treatment for DJJ Youth
A NA study of Substance Use, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 55
- Enrollment target
- 2
- Study locations
NCT06003725: Recruiting NA study of Substance Use, sponsored by University of California, San Francisco.
NCT06003725 is a NA study of Substance Use that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 55 participants, below the 1,260-participant average among 88 other Substance Use trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06003725, a NA study of Substance Use, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
- 2
- Study locations
Study Summary
This project aims to improve the understanding of the impact of Ethnic and Racial Discrimination (ERD) on adolescent alcohol and other drug use (AOD) within the Black Justice-Involved Youth (JIY) population. Individual interviews with Black JIY and focus groups with parents and guardians of Black JIY and community members who support change and reform in the justice community for Black JIY will be conducted.
Primary Outcome
Participants will complete feasibility and acceptability questionnaires and provide qualitative data on likes and dislikes about the intervention, delivery, session structure, and content.
Conditions Studied
Interventions
- BEHAVIORAL Culturally Adapted Adolescent Substance Use Treatment
Study Locations (2)
California
- University of California, San Francisco - San Francisco
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2024-05-15 |
| Est. Completion | 2027-08-30 |
| Phase | NA |
What NCT06003725 shows while recruiting
NCT06003725 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,260-participant average among 88 other Substance Use trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Substance Use appearing as the primary indexed condition, and to 1 intervention - of which Culturally Adapted Adolescent Substance Use Treatment is the first listed.
NCT06003725 reports a single indexed study location in California, South Carolina.
Frequently Asked Questions
What is clinical trial NCT06003725 about?
NCT06003725 is a clinical study titled "Cultural Adaptation of Drug Treatment for DJJ Youth". This project aims to improve the understanding of the impact of Ethnic and Racial Discrimination (ERD) on adolescent alcohol and other drug use (AOD) within the Black Justice-Involved Youth (JIY) population. Individual interviews with Black JIY and focus groups with parents and guardians of Black JI...
What is the current status of trial NCT06003725?
This trial is currently recruiting. It is a NA study. The enrollment target is 55 participants. The study started on 2024-05-15. Estimated completion is 2027-08-30.
What conditions does trial NCT06003725 study?
This clinical trial studies the following conditions: Substance Use.
What interventions are being tested in trial NCT06003725?
The interventions under investigation include: Culturally Adapted Adolescent Substance Use Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT06003725?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06003725 being conducted?
This trial has 2 study locations across California, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06003725's enrollment target sits among peer trials
55 75th of 88 higher than 14 of 88 other Substance Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
RECRUITING · NA
-
Primary Connections for Youth and Families
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI